1,200 articles
Michiel S. van der Heijden
Michiel S. van der Heijden is a Dutch medical oncologist and research group leader at the Netherlands Cancer Institute in Amsterdam, known for immunotherapy trials in bladder cancer.
Miguel Martín (oncologist)
Miguel Martín Jiménez is a Spanish medical oncologist specializing in breast cancer, head of medical oncology at the Gregorio Marañón hospital in Madrid since 2009.
Mikaël J. Pittet
Mikaël J. Pittet, also published as Mikael Pittet, is an onco-immunologist at the University of Geneva who studies how myeloid immune cells control tumor growth.
Mikala Egeblad
Mikala Egeblad is a Danish cancer biologist known for studies of the tumor microenvironment and neutrophils in metastasis, and for co-developing intravital microscopy of living tumors.
Min Chiu Li
Min Chiu Li (李敏求; 1919–1980) was an oncologist who produced the first drug cure of a solid cancer, metastatic choriocarcinoma, at the National Cancer Institute in 1956.
Min Yu
Min Yu is a Chinese-born physician-scientist studying circulating tumor cells, whose blood-based liquid biopsy work guides treatment of metastatic cancer; she won a 2015 NIH New Innovator Award.
Minesh P. Mehta
Minesh P. Mehta is a radiation oncologist and physician-scientist, deputy director and chief of radiation oncology at Baptist Health Miami Cancer Institute, and a brain tumor clinical trials leader.
Ming‐Sound Tsao
Ming-Sound Tsao is a Canadian thoracic pathologist and University of Toronto professor who studies lung cancer biomarkers at the Princess Margaret Cancer Centre in Toronto.
Mitchell H. Gail
Mitchell H. Gail is an American biostatistician who developed the Gail Model behind the NCI's Breast Cancer Risk Assessment Tool, spending his 1969 to 2025 career at the NCI.
Mohamed Bentires-Alj
Mohamed Bentires-Alj, born 1972, is a Moroccan-Belgian cancer biologist and professor of experimental surgical oncology at the University of Basel, known for work on breast cancer metastasis and therapy resistance.
Monica M. Bertagnolli
Monica M. Bertagnolli is an American surgical oncologist and colorectal cancer researcher who was the 16th director of the National Cancer Institute and the 17th director of the NIH.
Morris Pollard
Morris Pollard (1916–2011) was an American veterinary virologist and cancer researcher who directed the Lobund Laboratory at Notre Dame, studying leukemia and prostate cancer in germfree animals.
Mortimer B. Lipsett
Mortimer B. Lipsett (1921–1985) was an American endocrinologist and physician-scientist at the NIH who helped make choriocarcinoma the first cancer cured by chemotherapy alone, and held three NIH directorships.
Moshe Oren
Moshe Oren is an Israeli cancer molecular biologist at the Weizmann Institute of Science, known for his work on the p53 tumor suppressor protein and elected to the US National Academy of Sciences in 2019.
Mrinal M. Gounder
Mrinal M. Gounder is an American medical oncologist at Memorial Sloan Kettering Cancer Center specializing in sarcomas and desmoid tumors, and led the nirogacestat trials.
Muneesh Tewari
Muneesh Tewari is an American physician-scientist in hematology/oncology and biomedical engineering at the University of Michigan, known for pioneering circulating microRNAs as blood-based cancer biomarkers.
Murray F. Brennan
Murray F. Brennan is a New Zealand-born surgical oncologist who chaired surgery at Memorial Sloan Kettering Cancer Center from 1985 to 2006 and built a database of over 9,000 sarcoma patients.
Myles A. Brown
Myles A. Brown is an American physician-scientist who directs the Center for Functional Cancer Epigenetics at Dana-Farber and was elected to the National Academy of Sciences in 2016.
Myriam Chalabi
Myriam Chalabi is a Dutch medical oncologist and clinical group leader of gastrointestinal oncology at the Netherlands Cancer Institute in Amsterdam, known for the NICHE immunotherapy trials.
Nabeel Bardeesy
Nabeel Bardeesy is a Canadian-trained cancer biologist at Massachusetts General Hospital and Harvard Medical School, known for research on pancreatic and hepatobiliary cancers and tumor suppressor metabolism.
Nabil Djouder
Nabil Djouder is a French molecular biologist who heads the Growth Factors, Nutrients and Cancer Group at the Spanish National Cancer Research Centre in Madrid, studying the URI oncogene.
Nader Sanai
Nader Sanai is an American neurosurgeon and brain tumor researcher who is Chief of Neurosurgical Oncology at Barrow Neurological Institute in Phoenix, and founded the Ivy Brain Tumor Center.
Nadia Harbeck
Nadia Harbeck is a German breast oncologist who directs the Breast Center of the LMU women's hospital in Munich and led the IMpassion031 trial of atezolizumab in triple-negative breast cancer.
Nagahiro Saijo
Nagahiro Saijo (西條長宏) is a Japanese medical oncologist known for lung cancer drug trials, founding the Japan Society of Medical Oncology, and leading the JCOG 9511 trial.
Naiyer A Rizvi
Naiyer A Rizvi is a Canadian-trained American physician-scientist who led the CheckMate 063 trial behind nivolumab's lung cancer approval and served as Director of Thoracic Oncology at Columbia.
Nancy Berliner
Nancy Berliner is an American hematologist who leads the Division of Hematology at Brigham and Women's Hospital in Boston and is a leading expert on adult HLH.
Nancy E. Kemeny
Nancy E. Kemeny is an American medical oncologist at Memorial Sloan Kettering known for developing hepatic arterial infusion chemotherapy for colorectal cancer that has spread to the liver.
Nancy Raab‐Traub
Nancy Raab-Traub is an American virologist at the University of North Carolina at Chapel Hill known for her research on the Epstein–Barr virus and the cancers it causes.
Nancy Ratner
Nancy Ratner is an American Schwann-cell biologist and cancer researcher at Cincinnati Children's Hospital, known for identifying EGFR and MEK as drug targets in neurofibromatosis type 1.
Naomi Rosenberg
Naomi Rosenberg is an American microbiologist and cancer researcher who developed the first tractable in vitro model of leukemia development and served as dean at Tufts.